Sharp Therapeutics Corp. (SHRX)
Market Closed
7 Aug, 20:00
TSX-V TSX-V Primary CA$
0. 91
0
0%
CA$
63.16M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
CA$ 0.91
Previous Close Want to track SHRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sharp Therapeutics Corp. (SHRX) Statistics
Valuation metrics
Market Cap 63.16M
Enterprise value 87.33M
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) 32.45
Enterprise Value/Revenue -
Enterprise Value/EBITDA -11.54
Overview
Shares outstanding 30.08M
Float 16.43M
Shares short 16.3K
% Held by insiders 0.5%
% Held by institutions -
Average volume (10 days) 40
Average volume (90 days) 13
Price summary
52-Week low 0.23
52-Week high 5
Beta -1.06
50-Day moving average 2.17
200-Day moving average 2.18
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 27 Jan 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.06%
Return on equity -5.13%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -7.56M
Net income to common (ttm) -8.49M
Diluted EPS (ttm) -0.29
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 1.32M
Total cash per share (mrq) 0.03
Total debt (mrq) 1.76M
Total Debt/Equity (mrq) -9.99
Current ratio (mrq) 1.06%
Book value per share (mrq) 0.06
Cash Flow
Cash flow statement -6.65M
Levered free cash flow (LFCF) -4.17M
